Marie-Pierre Chauvet is an expert in Oncology at Centre Oscar Lambret (France). Marie-Pierre Chauvet has authored 108 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 227 (community average: 125). How the SLR is computed.

LeadR Profile

Marie-Pierre Chauvet Centre Oscar Lambret France
227 ScienceLeadR Reputation 227
Network Map

Oncology

Subspecialties: Surgery - Dermatology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026

Source: PubMed

Centre Oscar Lambret

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 108

Citations

Citations: 1 724 1st author: 3 Last author: 6 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Impact of Body Mass Index on Surgical Outcomes After Delayed Breast Reconstruction.
PMID 42788954 — body mass index, neoplasms, mammaplasty, breast, obesity, postoperative complications
J Surg Oncol20260
Ultrasound-guided blue dye localization of a clipped axillary lymph node after neoadjuvant chemotherapy in breast cancer a prospective feasibility study and critical review of axillary localization techniques.
PMID 42035610 — injections, feasibility studies, lymph nodes, breast neoplasms, neoplasms, sentinel lymph node, biopsy, drug therapy, lymph, breast, sentinel lymph node biopsy, dissection, chemotherapy
Surg Oncol20260
Inventory and needs assessment in francophone LMICs for education, screening and optimal management of breast cancer. The ELISA study.
PMID 41791919 — breast neoplasms, needs assessment, neoplasms, enzyme-linked immunosorbent assay, breast, therapeutics, education
Bull Cancer20260
Breast magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy and immunotherapy in early triple-negative breast cancer patients: prediction of pathological response and performance of ultrafast sequences.
PMID 40434685 — triple negative breast neoplasms, breast neoplasms, neoplasms, magnetic resonance imaging, drug therapy, immunotherapy, breast, chemotherapy
Breast Cancer Res Treat20250
Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery.
PMID 39409937 — mastectomy, breast neoplasms, cyclin-dependent kinase 4, neoplasms, sentinel lymph node, aged, cyclin-dependent kinases, cyclins, breast, therapeutics
Cancers (Basel)20240

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 3 1

By status:

Recruiting 2
Completed 1

By type:

Interventional 2
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map